• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19.微生物负荷相关的细胞因子风暴可能解释新冠病毒疾病患者无法缓解的急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1182-1183. doi: 10.1164/rccm.202207-1266LE.
2
Reply to: Microbial Burden-associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients.回复：微生物负荷相关的细胞因子风暴可能解释COVID-19患者中无法缓解的急性呼吸窘迫综合征
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1183-1184. doi: 10.1164/rccm.202207-1346LE.
3
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.新冠疫情下的风暴：对 SARS-CoV-2 细胞因子风暴当前认识和治疗机会的一瞥。
Curr Pharm Des. 2021;27(13):1549-1552. doi: 10.2174/1381612826666201125102649.
4
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.固有受体激活模式涉及 COVID-19、ALI/ARDS 和脓毒症细胞因子风暴中的 TLR 和 NLR 协同作用：综述和模型制作新的预测和治疗建议。
Int J Mol Sci. 2021 Feb 20;22(4):2108. doi: 10.3390/ijms22042108.
5
Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.血红素加氧酶-1（HO-1）细胞保护途径：一种针对 2019 年冠状病毒病（COVID-19）诱导的细胞因子风暴综合征的潜在治疗策略。
Med Hypotheses. 2020 Nov;144:110242. doi: 10.1016/j.mehy.2020.110242. Epub 2020 Sep 3.
6
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者：一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
7
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted.SARS-CoV-2 感染有基础肝病的人群：需要进一步研究。
World J Gastroenterol. 2021 Dec 7;27(45):7855-7858. doi: 10.3748/wjg.v27.i45.7855.
8
Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.托珠单抗治疗 COVID-19 诱导的细胞因子风暴和急性呼吸窘迫综合征：来自宾夕法尼亚州西部农村一级创伤中心的病例系列。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211019557. doi: 10.1177/23247096211019557.
9
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.治疗靶点：SARS-CoV-2 感染诱导的细胞死亡。
Front Immunol. 2022 May 17;13:870216. doi: 10.3389/fimmu.2022.870216. eCollection 2022.
10
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.COVID-19 相关急性呼吸窘迫综合征和肺外多器官功能障碍患者炎症细胞因子风暴中的特定细胞因子。
Virol J. 2021 Jun 4;18(1):117. doi: 10.1186/s12985-021-01588-y.

引用本文的文献

1
Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity.炎症细胞因子变体对全身炎症谱及新冠病毒疾病严重程度的影响
J Epidemiol Glob Health. 2024 Jun;14(2):363-378. doi: 10.1007/s44197-024-00204-w. Epub 2024 Feb 20.

本文引用的文献

1
Untangling Lower Airway Dysbiosis in Critically Ill Patients with COVID-19.解析新冠重症患者下呼吸道微生物群失调
Am J Respir Crit Care Med. 2022 Oct 1;206(7):806-808. doi: 10.1164/rccm.202206-1074ED.
2
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.COVID-19 危重症患者的肺部微生物群与非解决性急性呼吸窘迫综合征相关。
Am J Respir Crit Care Med. 2022 Oct 1;206(7):846-856. doi: 10.1164/rccm.202202-0274OC.
3
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury.四环素抑制 Caspase-1 可改善急性肺损伤。
Am J Respir Crit Care Med. 2021 Jul 1;204(1):53-63. doi: 10.1164/rccm.202005-1916OC.
4
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.严重和危重新冠肺炎中的细胞因子升高：快速系统评价、荟萃分析，并与其他炎症综合征比较。
Lancet Respir Med. 2020 Dec;8(12):1233-1244. doi: 10.1016/S2213-2600(20)30404-5. Epub 2020 Oct 16.
5
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.COVID-19 急性呼吸窘迫综合征患者的失控固有和受损适应性免疫反应。
Am J Respir Crit Care Med. 2020 Dec 1;202(11):1509-1519. doi: 10.1164/rccm.202005-1885OC.

Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19.

作者信息

Yasuma Taro, D'Alessandro-Gabazza Corina N, Kobayashi Tetsu, Gabazza Esteban C, Fujimoto Hajime

机构信息

Mie University Tsu, Mie, Japan.

出版信息

Am J Respir Crit Care Med. 2022 Nov 1;206(9):1182-1183. doi: 10.1164/rccm.202207-1266LE.

DOI:10.1164/rccm.202207-1266LE
PMID:35867882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9704827/
Abstract
摘要